Isabel Losantos, senior consultant - Design Assurance, at Cambridge Consultants and Joe Corrigan, head of Medical Technology examine the potential AI represents in life sciences and the regulatory changes it brings.
EPM speaks to Paul Burden, chief commercial officer – Strategic Growth, at ADVANZ PHARMA about niche medicines, the challenges of working with multiple partners and why competition is everywhere in pharma.
Med-Tech Innovation editor Ian Bolland speaks to Lionel Maritan, associate director – research and development Becton Dickinson (BD), about the company’s Intevia 2.25ml autoinjector which is set to launch at the end of 2021 or the start of 2022.
EPM speaks to Patrick Malone, vice president, Operations, Contract Manufacturing at West Pharmaceutical Services, about the essentials in contract manufacturing and the latest trends affect manufacturers.
Med-Tech Innovation editor Ian Bolland speaks to life sciences supplier Abcam about the company’s latest efforts to develop a new cell delivery solution that can potentially improve the therapeutic viability of molecules.
State-of-the-art-tableting technology meets the midrange segment at last. The days of having to compromise are over. KORSCH is introducing a groundbreaking mid-range tablet press incorporating
European Pharmaceutical Manufacturer sits down with Derek Wang, CEO of data analytics company Stratifyd, to discuss the Covid-19 pandemic and how technology can be better used to predict and potentially curtail disease outbreaks.
Sukirti Kalra clinical project manager and Colin Newboul, head of Global Regulatory Affairs & Quality at Wasdell Group examine how clinical trials are adapting with the ongoing Covid-19 pandemic.
EPM speaks to Abdullah Al-Hakimi, senior quality compliance specialist at Autolus and Robert Gaertner, strategy director for Veeva Vault Quality, about working during Covid-19 and why quality processes are so important in pharma.
